Drug firm Lupin names Claus Jepsen as President Global specialty business
Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases
 "Claus Jepsen")
Claus Jepsen
Listen to This Article
Drug firm Lupin on Monday said it has appointed Claus Jepsen as President, Global Specialty business.
Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases.
"His experience in leading specialty strategy, commercial planning and portfolio choices across key markets will enable us to build our Specialty brand business," Lupin CEO Vinita Gupta said.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
More From This Section
 "Ratan Tata")
 "Ratan Tata")
 "Partha Sengupta")
 "Ratan Tata and N Chandrasekaran")
 "Bhavish Aggarwal has hinted at the launch of two more models, the Sportster and Arrowhead, in the near future")
Topics : Lupin Drug makers in India Pharma industry
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 21 2024 | 11:52 PM IST